Heart Failure, Congestive Clinical Trial
Official title:
A Family Intervention for Improving Self-Care of Patients With Heart Failure
This is a pilot study of a family-based educational program for patients with heart failure, and their family members.
1. Objectives(s): We plan to conduct a feasibility pilot trial of the Family Partnership
Intervention (FPI) compared to patients in the HF Wait-list (WL) condition. We plan to
demonstrate feasibility, estimate variances of major outcome variables, and to obtain
preliminary estimates of effect sizes in preparation for subsequent grant applications.
We will be able to develop a cost-effectiveness model for the relative benefit of FPI
vs. no family-based for use in longer-term studies.
2. Research Design: This is a short-term, randomized clinical trial which will involve
assessments for participants in the FPI condition at a pre-intervention Baseline point,
immediately post-intervention, and 6 months post-intervention. Participants in the WL
condition will be assessed at Baseline, undergo an approximately 8 week waiting period,
and then the FPI. A longer follow-up is not planned based on the purpose of this study
as a feasibility trial.
3. Methodology: We plan to randomize 40 Veterans and their family members to either the
FPI condition or WL condition, in equal proportions. We will recruit patients with at
least Stage C Heart Failure (NYHA class I - IV) from the Cardiology clinic of the
Philadelphia VAMC. FPI will involve 4-6 hours of intervention delivered over a period
of 6-8 weeks. Assessments at a pre-treatment baseline point, 8 weeks (immediately
post-treatment), and 6 months will cover the following domains: a) patients'
demographic characteristics and clinical functioning, b) self-care, including
self-management of symptoms, knowledge of HF, and adherence to medication and dietary
intake of sodium, c) measures of family functioning relevant to the medical care of the
patient, and d) health care utilization costs. Primary outcome measures will be
patients' self-reported HF self-care and health care utilization costs. We anticipate
that patients in the FPI condition will exhibit better self-care over time compared to
patients in the WL condition. We also anticipate that patients and family members will
exhibit an improved family environment and better HF knowledge.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |